Selected research
Market Analysis & Forecast
Global Particle Engineering Market Analysis and Forecast 2026-2032
Market perspective
The global Particle Engineering market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Particle Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Particle Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Particle Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Particle Engineering is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Particle Engineering include EUROAPI, Balchem, Lonza, Hovione, Coating Place, XEDEV BV, CritiTech, SK Biotek and Schedio, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Particle Engineering, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Particle Engineering, also provides the revenue of main regions and countries. Of the upcoming market potential for Particle Engineering, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Particle Engineering revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Particle Engineering market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Particle Engineering revenue, projected growth trends, production technology, application and end-user industry.
Particle Engineering Segment by Company
EUROAPI
Balchem
Lonza
Hovione
Coating Place
XEDEV BV
CritiTech
SK Biotek
Schedio
Evonik Industries
Veranova
APC
Serán Bioscience
Particle Engineering Segment by Type
Oral Drug
Parenteral Drug
Inhaled Drug
Particle Engineering Segment by Application
Pharmaceutical
Biotechnology
Clinical
Others
Particle Engineering Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Particle Engineering market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Particle Engineering and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Particle Engineering.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Particle Engineering in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Particle Engineering company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Particle Engineering revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Drug
- Parenteral Drug
- Inhaled Drug
Applications
- Pharmaceutical
- Biotechnology
- Clinical
- Others
Companies covered
- EUROAPI
- Balchem
- Lonza
- Hovione
- Coating Place
- XEDEV BV
- CritiTech
- SK Biotek
- Schedio
- Evonik Industries
- Veranova
- APC
- Serán Bioscience
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Particle Engineering Market by Type
- 1.2.1 Global Particle Engineering Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Oral Drug
- 1.2.3 Parenteral Drug
- 1.2.4 Inhaled Drug
- 1.3 Particle Engineering Market by Application
- 1.3.1 Global Particle Engineering Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical
- 1.3.3 Biotechnology
- 1.3.4 Clinical
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Particle Engineering Market Dynamics
- 2.1 Particle Engineering Industry Trends
- 2.2 Particle Engineering Industry Drivers
- 2.3 Particle Engineering Industry Opportunities and Challenges
- 2.4 Particle Engineering Industry Restraints
3 Global Growth Perspective
- 3.1 Global Particle Engineering Market Perspective (2021-2032)
- 3.2 Global Particle Engineering Growth Trends by Region
- 3.2.1 Global Particle Engineering Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Particle Engineering Market Size by Region (2021-2026)
- 3.2.3 Global Particle Engineering Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Particle Engineering Revenue by Players
- 4.1.1 Global Particle Engineering Revenue by Players (2021-2026)
- 4.1.2 Global Particle Engineering Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Particle Engineering Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Particle Engineering Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Particle Engineering Key Players Headquarters & Area Served
- 4.4 Global Particle Engineering Players, Product Type & Application
- 4.5 Global Particle Engineering Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Particle Engineering Market CR5 and HHI
- 4.6.3 2025 Particle Engineering Tier 1, Tier 2, and Tier 3
5 Particle Engineering Market Size by Type
- 5.1 Global Particle Engineering Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Particle Engineering Revenue by Type (2021-2032)
- 5.3 Global Particle Engineering Revenue Market Share by Type (2021-2032)
6 Particle Engineering Market Size by Application
- 6.1 Global Particle Engineering Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Particle Engineering Revenue by Application (2021-2032)
- 6.3 Global Particle Engineering Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 EUROAPI
- 7.1.1 EUROAPI Company Information
- 7.1.2 EUROAPI Business Overview
- 7.1.3 EUROAPI Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.1.4 EUROAPI Particle Engineering Product Portfolio
- 7.1.5 EUROAPI Recent Developments
- 7.2 Balchem
- 7.2.1 Balchem Company Information
- 7.2.2 Balchem Business Overview
- 7.2.3 Balchem Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.2.4 Balchem Particle Engineering Product Portfolio
- 7.2.5 Balchem Recent Developments
- 7.3 Lonza
- 7.3.1 Lonza Company Information
- 7.3.2 Lonza Business Overview
- 7.3.3 Lonza Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.3.4 Lonza Particle Engineering Product Portfolio
- 7.3.5 Lonza Recent Developments
- 7.4 Hovione
- 7.4.1 Hovione Company Information
- 7.4.2 Hovione Business Overview
- 7.4.3 Hovione Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.4.4 Hovione Particle Engineering Product Portfolio
- 7.4.5 Hovione Recent Developments
- 7.5 Coating Place
- 7.5.1 Coating Place Company Information
- 7.5.2 Coating Place Business Overview
- 7.5.3 Coating Place Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.5.4 Coating Place Particle Engineering Product Portfolio
- 7.5.5 Coating Place Recent Developments
- 7.6 XEDEV BV
- 7.6.1 XEDEV BV Company Information
- 7.6.2 XEDEV BV Business Overview
- 7.6.3 XEDEV BV Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.6.4 XEDEV BV Particle Engineering Product Portfolio
- 7.6.5 XEDEV BV Recent Developments
- 7.7 CritiTech
- 7.7.1 CritiTech Company Information
- 7.7.2 CritiTech Business Overview
- 7.7.3 CritiTech Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.7.4 CritiTech Particle Engineering Product Portfolio
- 7.7.5 CritiTech Recent Developments
- 7.8 SK Biotek
- 7.8.1 SK Biotek Company Information
- 7.8.2 SK Biotek Business Overview
- 7.8.3 SK Biotek Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.8.4 SK Biotek Particle Engineering Product Portfolio
- 7.8.5 SK Biotek Recent Developments
- 7.9 Schedio
- 7.9.1 Schedio Company Information
- 7.9.2 Schedio Business Overview
- 7.9.3 Schedio Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.9.4 Schedio Particle Engineering Product Portfolio
- 7.9.5 Schedio Recent Developments
- 7.10 Evonik Industries
- 7.10.1 Evonik Industries Company Information
- 7.10.2 Evonik Industries Business Overview
- 7.10.3 Evonik Industries Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.10.4 Evonik Industries Particle Engineering Product Portfolio
- 7.10.5 Evonik Industries Recent Developments
- 7.11 Veranova
- 7.11.1 Veranova Company Information
- 7.11.2 Veranova Business Overview
- 7.11.3 Veranova Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.11.4 Veranova Particle Engineering Product Portfolio
- 7.11.5 Veranova Recent Developments
- 7.12 APC
- 7.12.1 APC Company Information
- 7.12.2 APC Business Overview
- 7.12.3 APC Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.12.4 APC Particle Engineering Product Portfolio
- 7.12.5 APC Recent Developments
- 7.13 Serán Bioscience
- 7.13.1 Serán Bioscience Company Information
- 7.13.2 Serán Bioscience Business Overview
- 7.13.3 Serán Bioscience Particle Engineering Revenue and Gross Margin (2021-2026)
- 7.13.4 Serán Bioscience Particle Engineering Product Portfolio
- 7.13.5 Serán Bioscience Recent Developments
8 North America
- 8.1 North America Particle Engineering Revenue (2021-2032)
- 8.2 North America Particle Engineering Revenue by Type (2021-2032)
- 8.2.1 North America Particle Engineering Revenue by Type (2021-2026)
- 8.2.2 North America Particle Engineering Revenue by Type (2027-2032)
- 8.3 North America Particle Engineering Revenue Share by Type (2021-2032)
- 8.4 North America Particle Engineering Revenue by Application (2021-2032)
- 8.4.1 North America Particle Engineering Revenue by Application (2021-2026)
- 8.4.2 North America Particle Engineering Revenue by Application (2027-2032)
- 8.5 North America Particle Engineering Revenue Share by Application (2021-2032)
- 8.6 North America Particle Engineering Revenue by Country
- 8.6.1 North America Particle Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Particle Engineering Revenue by Country (2021-2026)
- 8.6.3 North America Particle Engineering Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Particle Engineering Revenue (2021-2032)
- 9.2 Europe Particle Engineering Revenue by Type (2021-2032)
- 9.2.1 Europe Particle Engineering Revenue by Type (2021-2026)
- 9.2.2 Europe Particle Engineering Revenue by Type (2027-2032)
- 9.3 Europe Particle Engineering Revenue Share by Type (2021-2032)
- 9.4 Europe Particle Engineering Revenue by Application (2021-2032)
- 9.4.1 Europe Particle Engineering Revenue by Application (2021-2026)
- 9.4.2 Europe Particle Engineering Revenue by Application (2027-2032)
- 9.5 Europe Particle Engineering Revenue Share by Application (2021-2032)
- 9.6 Europe Particle Engineering Revenue by Country
- 9.6.1 Europe Particle Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Particle Engineering Revenue by Country (2021-2026)
- 9.6.3 Europe Particle Engineering Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Particle Engineering Revenue (2021-2032)
- 10.2 China Particle Engineering Revenue by Type (2021-2032)
- 10.2.1 China Particle Engineering Revenue by Type (2021-2026)
- 10.2.2 China Particle Engineering Revenue by Type (2027-2032)
- 10.3 China Particle Engineering Revenue Share by Type (2021-2032)
- 10.4 China Particle Engineering Revenue by Application (2021-2032)
- 10.4.1 China Particle Engineering Revenue by Application (2021-2026)
- 10.4.2 China Particle Engineering Revenue by Application (2027-2032)
- 10.5 China Particle Engineering Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Particle Engineering Revenue (2021-2032)
- 11.2 Asia Particle Engineering Revenue by Type (2021-2032)
- 11.2.1 Asia Particle Engineering Revenue by Type (2021-2026)
- 11.2.2 Asia Particle Engineering Revenue by Type (2027-2032)
- 11.3 Asia Particle Engineering Revenue Share by Type (2021-2032)
- 11.4 Asia Particle Engineering Revenue by Application (2021-2032)
- 11.4.1 Asia Particle Engineering Revenue by Application (2021-2026)
- 11.4.2 Asia Particle Engineering Revenue by Application (2027-2032)
- 11.5 Asia Particle Engineering Revenue Share by Application (2021-2032)
- 11.6 Asia Particle Engineering Revenue by Country
- 11.6.1 Asia Particle Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Particle Engineering Revenue by Country (2021-2026)
- 11.6.3 Asia Particle Engineering Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Particle Engineering Revenue (2021-2032)
- 12.2 SAMEA Particle Engineering Revenue by Type (2021-2032)
- 12.2.1 SAMEA Particle Engineering Revenue by Type (2021-2026)
- 12.2.2 SAMEA Particle Engineering Revenue by Type (2027-2032)
- 12.3 SAMEA Particle Engineering Revenue Share by Type (2021-2032)
- 12.4 SAMEA Particle Engineering Revenue by Application (2021-2032)
- 12.4.1 SAMEA Particle Engineering Revenue by Application (2021-2026)
- 12.4.2 SAMEA Particle Engineering Revenue by Application (2027-2032)
- 12.5 SAMEA Particle Engineering Revenue Share by Application (2021-2032)
- 12.6 SAMEA Particle Engineering Revenue by Country
- 12.6.1 SAMEA Particle Engineering Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Particle Engineering Revenue by Country (2021-2026)
- 12.6.3 SAMEA Particle Engineering Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst